UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000011791
Receipt number R000013786
Scientific Title A phase II study of Erlotinib and Bevacizumab combination therapy for previously treated III B / IV Stage non-squamous non-small cell lung cancer: IMSLC-001
Date of disclosure of the study information 2013/09/18
Last modified on 2013/09/18 13:54:30

No. Disposal Last modified on Item of update
1 Insert 2013/09/18 13:55:20